Detalhe da pesquisa
1.
Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR.
Nucleic Acids Res
; 2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37144485
2.
PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells.
Int J Mol Sci
; 24(20)2023 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37895093
3.
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Br J Cancer
; 126(9): 1264-1270, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992255
4.
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1).
Int J Cancer
; 148(3): 682-691, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405269
5.
Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples.
Br J Cancer
; 122(3): 397-404, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31792349
6.
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer.
Clin Chem
; 66(8): 1093-1101, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712650
7.
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
Breast Cancer Res Treat
; 177(3): 659-667, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297647
8.
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
BMC Cancer
; 19(1): 110, 2019 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700265
9.
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.
Br J Cancer
; 119(1): 76-79, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880907
10.
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Int J Cancer
; 139(10): 2299-311, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27464303
11.
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.
BMC Cancer
; 16: 428, 2016 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27387327
12.
Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.
J Genet Couns
; 25(3): 432-42, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26392361
13.
High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers.
BMC Cancer
; 15: 986, 2015 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26680641
14.
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Dig Liver Dis
; 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233313
15.
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.
BMC Cancer
; 13: 523, 2013 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24191908
16.
A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer.
Sci Rep
; 13(1): 2739, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792801
17.
BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib.
Front Oncol
; 13: 1125021, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37007122
18.
Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodies.
J Biol Chem
; 286(13): 11337-45, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21282108
19.
KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment.
Mod Pathol
; 25(5): 731-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22282307
20.
In situ hybridization for the assessment of urokinase plasminogen activator and plasminogen activator inhibitor type1 in formalinfixed paraffinembedded breast cancer specimens.
Int J Mol Med
; 49(6)2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35475537